The company has received notifications about transactions in the Issuer’s securities.
The person authorized to provide additional information:
Kazimieras Tonkūnas
INVL Technology Managing Partner
e-mail k.tonkunas@invltechnology.lt
Attachments
HYDERABAD, India, December 15, 2025 /PRNewswire/ -- According to Mordor Intelligence, the healthcare IT market …
Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry…
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)…
PALO ALTO, CALIFORNIA / ACCESS Newswire / December 15, 2025 / Bioz, Inc., the leading…
GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX)…
Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…